Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REOLYSIN with Paclitaxel and Carboplatin in SCCHN
NCT01166542Phase 3Completed
- Sponsor
- Oncolytics Biotech Inc.
- Start
- Jun 2010
- Primary completion
- Apr 2012
- Modality
- Oncolytic Viruses, Recombinant Proteins and Enzymes
- Countries
- 13
01
Overview
A Phase 3 trial of pelareorep in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Oncolytics Biotech Inc.. Started Jun 2010; status: completed.
02
Drugs
pelareorep
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01166542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01166542.